Early-onset Type 2 Diabetes Impairs Skeletal Acquisition in the Male TALLYHO/JngJ Mouse

Overview

Journal Endocrinology

Publisher Oxford University Press

Specialty Endocrinology

Date 2014 Jul 23

PMID 25051433

Citations 48

Authors

M J Devlin

M van Vliet

K Motyl

L Karim

D J Brooks

L Louis

C Conlon

C J Rosen

M L Bouxsein

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes (T2D) incidence in adolescents is rising and may interfere with peak bone mass acquisition. We tested the effects of early-onset T2D on bone mass, microarchitecture, and strength in the TALLYHO/JngJ mouse, which develops T2D by 8 weeks of age. We assessed metabolism and skeletal acquisition in male TALLYHO/JngJ and SWR/J controls (n = 8-10/group) from 4 weeks to 8 and 17 weeks of age. Tallyho mice were obese; had an approximately 2-fold higher leptin and percentage body fat; and had lower bone mineral density vs SWR at all time points (P < .03 for all). Tallyho had severe deficits in distal femur trabecular bone volume fraction (-54%), trabecular number (-27%), and connectivity density (-82%) (P < .01 for all). Bone formation was higher in Tallyho mice at 8 weeks but lower by 17 weeks of age vs SWR despite similar numbers of osteoblasts. Bone marrow adiposity was 7- to 50-fold higher in Tallyho vs SWR. In vitro, primary bone marrow stromal cell differentiation into osteoblast and adipocyte lineages was similar in SWR and Tallyho, suggesting skeletal deficits were not due to intrinsic defects in Tallyho bone-forming cells. These data suggest the Tallyho mouse might be a useful model to study the skeletal effects of adolescent T2D.

Citing Articles

Differential microRNA expression patterns between TallyHo/JngJ mice and non-diabetic Swiss Webster Random/Jackson mice.

Carro Vazquez D, Emini L, Rauner M, Hofbauer C, Skalicky S, Wagner A JBMR Plus. 2024; 9(1):ziae121.

PMID: 39664932 PMC: 11631062. DOI: 10.1093/jbmrpl/ziae121.

Bone Marrow Adiposity Alterations in Postmenopausal Women With Type 2 Diabetes Are Site-Specific.

Badr S, Cotten A, Lombardo D, Ruschke S, Karampinos D, Ramdane N J Endocr Soc. 2024; 8(11):bvae161.

PMID: 39381685 PMC: 11458911. DOI: 10.1210/jendso/bvae161.

Function and Regulation of Bone Marrow Adipose Tissue in Health and Disease: State of the Field and Clinical Considerations.

Zhang X, Tian L, Majumdar A, Scheller E Compr Physiol. 2024; 14(3):5521-5579.

PMID: 39109972 PMC: 11725182. DOI: 10.1002/cphy.c230016.

Bone Marrow Adipose Tissue.

Marinelli Busilacchi E, Morsia E, Poloni A Cells. 2024; 13(9.

PMID: 38727260 PMC: 11083575. DOI: 10.3390/cells13090724.

Utility and Limitations of TALLYHO/JngJ as a Model for Type 2 Diabetes-Induced Bone Disease.

Emini L, Salbach-Hirsch J, Krug J, Jahn-Rickert K, Busse B, Rauner M JBMR Plus. 2023; 7(12):e10843.

PMID: 38130754 PMC: 10731141. DOI: 10.1002/jbm4.10843.

References

Bonjour J, Theintz G, Buchs B, Slosman D, Rizzoli R . Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab. 1991; 73(3):555-63. DOI: 10.1210/jcem-73-3-555. View

Bachrach L, Katzman D, Litt I, Guido D, Marcus R . Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 1991; 72(3):602-6. DOI: 10.1210/jcem-72-3-602. View

Botolin S, Faugere M, Malluche H, Orth M, Meyer R, McCabe L . Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology. 2005; 146(8):3622-31. PMC: 1242186. DOI: 10.1210/en.2004-1677. View

Baum T, Yap S, Karampinos D, Nardo L, Kuo D, Burghardt A . Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?. J Magn Reson Imaging. 2011; 35(1):117-24. PMC: 3245661. DOI: 10.1002/jmri.22757. View

Richards J, Valdes A, Burling K, Perks U, Spector T . Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab. 2007; 92(4):1517-23. DOI: 10.1210/jc.2006-2097. View

Clee S, Attie A . The genetic landscape of type 2 diabetes in mice. Endocr Rev. 2006; 28(1):48-83. DOI: 10.1210/er.2006-0035. View

Doniach D . Possible stimulation of thermogenesis in brown adipose tissue by thyroid-stimulating hormone. Lancet. 1975; 2(7926):160-1. DOI: 10.1016/s0140-6736(75)90061-6. View

Sayinalp S, Gedik O, Koray Z . Increasing serum osteocalcin after glycemic control in diabetic men. Calcif Tissue Int. 1995; 57(6):422-5. DOI: 10.1007/BF00301944. View

Devlin M, Cloutier A, Thomas N, Panus D, Lotinun S, Pinz I . Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J Bone Miner Res. 2010; 25(9):2078-88. PMC: 3127399. DOI: 10.1002/jbmr.82. View

10.

Pollock N, Bernard P, Wenger K, Misra S, Gower B, Allison J . Lower bone mass in prepubertal overweight children with prediabetes. J Bone Miner Res. 2010; 25(12):2760-9. PMC: 3122138. DOI: 10.1002/jbmr.184. View

11.

Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T . Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res. 2008; 24(4):702-9. DOI: 10.1359/jbmr.081207. View

12.

Linder C . The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases. Lab Anim (NY). 2001; 30(5):34-9. View

13.

Schwartz A, Garnero P, Hillier T, Sellmeyer D, Strotmeyer E, Feingold K . Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2009; 94(7):2380-6. PMC: 2708944. DOI: 10.1210/jc.2008-2498. View

14.

Rosato M, Schneider S, Shapses S . Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int. 1998; 63(2):107-11. DOI: 10.1007/s002239900498. View

15.

Afghani A, Cruz M, Goran M . Impaired glucose tolerance and bone mineral content in overweight latino children with a family history of type 2 diabetes. Diabetes Care. 2005; 28(2):372-8. DOI: 10.2337/diacare.28.2.372. View

16.

Schwartz A, Vittinghoff E, Bauer D, Hillier T, Strotmeyer E, Ensrud K . Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011; 305(21):2184-92. PMC: 3287389. DOI: 10.1001/jama.2011.715. View

17.

Luo X, Guo L, Yuan L, Xie H, Zhou H, Wu X . Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res. 2005; 309(1):99-109. DOI: 10.1016/j.yexcr.2005.05.021. View

18.

Dempster D, Compston J, Drezner M, Glorieux F, Kanis J, Malluche H . Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2012; 28(1):2-17. PMC: 3672237. DOI: 10.1002/jbmr.1805. View

19.

Botolin S, McCabe L . Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem. 2006; 99(2):411-24. DOI: 10.1002/jcb.20842. View

20.

Burghardt A, Issever A, Schwartz A, Davis K, Masharani U, Majumdar S . High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010; 95(11):5045-55. PMC: 2968722. DOI: 10.1210/jc.2010-0226. View